369 related articles for article (PubMed ID: 28583827)
21. Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden.
Bosi A; Clase CM; Ceriani L; Sjölander A; Fu EL; Runesson B; Chang Z; Landén M; Bellocco R; Elinder CG; Carrero JJ
JAMA Netw Open; 2023 Jul; 6(7):e2322056. PubMed ID: 37418264
[TBL] [Abstract][Full Text] [Related]
22. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
23. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
[TBL] [Abstract][Full Text] [Related]
25. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
26. PPIs and kidney disease: from AIN to CKD.
Moledina DG; Perazella MA
J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
[TBL] [Abstract][Full Text] [Related]
27. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
28. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
[TBL] [Abstract][Full Text] [Related]
29. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
[TBL] [Abstract][Full Text] [Related]
30. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
31. Renal function changes after fenestrated endovascular aneurysm repair.
Tran K; Fajardo A; Ullery BW; Goltz C; Lee JT
J Vasc Surg; 2016 Aug; 64(2):273-280. PubMed ID: 27237402
[TBL] [Abstract][Full Text] [Related]
32. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
33. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.
Malmgren L; McGuigan FE; Berglundh S; Westman K; Christensson A; Åkesson K
Nephron; 2015; 130(4):245-55. PubMed ID: 26184510
[TBL] [Abstract][Full Text] [Related]
34. Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort.
Han SW; Tilea A; Gillespie BW; Finkelstein FO; Kiser MA; Eisele G; Kotanko P; Levin N; Saran R
Am J Nephrol; 2015; 41(3):200-9. PubMed ID: 25871915
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
[TBL] [Abstract][Full Text] [Related]
36. Incidence of acute kidney injury among patients with chronic kidney disease: a single-center retrospective database analysis.
Hatakeyama Y; Horino T; Kataoka H; Matsumoto T; Ode K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Terada Y; Okuhara Y
Clin Exp Nephrol; 2017 Feb; 21(1):43-48. PubMed ID: 26879775
[TBL] [Abstract][Full Text] [Related]
37. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.
Vangala C; Niu J; Lenihan CR; Mitch WE; Navaneethan SD; Winkelmayer WC
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1534-1541. PubMed ID: 30262672
[TBL] [Abstract][Full Text] [Related]
38. New Criterion to Evaluate Acute-on-Chronic Kidney Injury Based on the Creatinine Reference Change.
Xu X; Wang L; Xiong M; Nie S; Liu Z; Feng Y; Chen C; Zha Y; Ou J; Ge S; Chen J; Wan Q; Teng S; Hao CM; Liu BC; Xu A; Feng JH; Zhang A; Mao J; Liu HP; Liang H; Shen Q; Feng S; Zhou W; Liu X; Yang Y; Tao Y; Wang M; Wang LJ; Qi JL; Li Y; Su L; Hou FF
Am J Nephrol; 2020; 51(6):453-462. PubMed ID: 32349004
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Shimizu M; Furuichi K; Wada T
Nephrol Dial Transplant; 2019 Jul; 34(7):1182-1188. PubMed ID: 29788462
[TBL] [Abstract][Full Text] [Related]
40. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
